Actelion profile and corporate video
Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.
Actelion focuses on the manufacture of drugs that treat rare diseases and orphan diseases. Some of the drugs it has produced have been used to treat patients with symptoms related to central nervous system disorders, irregular heart conditions, immune system disorders and cancer.
In January 2017, Johnson & Johnson announced that it would purchase Actelion. Actelion’s research and development unit would also be spun off after the acquisition. The new company Idorsia was created from former Actelion drug discovery operations and early-stage clinical development assets
*Information from Forbes.com and Actelion.com
**Video published on YouTube by “Janssen Global“